Pharmacological mechanisms of antidepressant-like effect of tipepidine in the forced swimming test

Behavioural Brain Research

Volumn 226, Issue 2, 2012, Pages 381-385

  Kawaura, Kazuaki ^a   Miki, Risa ^a   Urashima, Yuri ^a   Kawahara, Ryo ^a   Soeda, Fumio ^a   Shirasaki, Tetsuya ^a   Takahama, Kazuo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antidepressant like effect; Antitussive; Dopamine; G protein inwardly rectifying potassium ion channel; Noradrenaline; Tipepidine

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 2 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; FENCLONINE; METIROSINE; PRAZOSIN; PROPRANOLOL; RACLOPRIDE; TIPEPIDINE; YOHIMBINE;

ADRENERGIC TRANSMISSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG MECHANISM; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

ALPHA-METHYLTYROSINE; ANIMALS; ANTIDEPRESSIVE AGENTS; BENZAZEPINES; DRUG INTERACTIONS; FENCLONINE; IMMOBILITY RESPONSE, TONIC; MALE; MOTOR ACTIVITY; PIPERIDINES; PRAZOSIN; PROPRANOLOL; RACLOPRIDE; RATS; RATS, WISTAR; YOHIMBINE;

EID: 81355146388     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.031     Document Type: Article

References (34)

1. Kawaura K., Ogata Y., Inoue M., Honda S., Soeda F., Shirasaki T., et al. The centrally acting non-narcotic antitussive tipepidine produces antidepressant-like effect in the forced swimming test in rats. Behav Brain Res 2009, 205:315-318.
2. Kawaura K., Urashima Y., Miki R., Honda S., Soeda F., Shirasaki T., et al. Studies on the mechanism of a novel antidepressant-like action of tipepidine in rats. J Pharmacol Sci 2011, 115(Suppl. 1):197P.
3. Kitamura Y., Araki H., Gomita Y. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav 2002, 71:63-69.
4. + current by dextromethorphan in rat dorsal raphe neurones. Neuropharmacology 2000, 39:2302-2308.
5. Takahama K., Shirasaki T., Soeda F. Central mechanisms: neuronal mechanisms of action centrally acting antitussives using electrophysiological and neurochemical study approaches. Handbook of experimental pharmacology; pharmacology and therapeutics of cough 2009, vol. 187:219-240. Springer-Verlag, Berlin.
6. North R.A. Twelfth Gaddum memorial lecture. Drug receptors and the inhibition of nerve cells. Br J Pharmacol 1989, 98:13-28.
7. Signorini S., Liao Y.J., Duncan S.A., Jan L.Y., Stoffel M. Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2. Proc Natl Acad Sci USA 1997, 94:923-927.
8. Wickman K., Nemec J., Gendler S.J., Clapham D.E. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 1998, 20:103-114.
9. Inoue M., Shirasaki T., Soeda F., Takahama K. Effect of cloperastine on 5-HT level in rat prefrontal cortex: An in vivo microdialysis study. J Pharmacol Sci 2008, 106(Suppl. 1):187P.
10. Inoue M., Kawaura K., Ogata Y., Honda S., Shirasaki T., Soeda F., et al. Cloperastine remarkably increased the level of DA compared to the level of 5-HT in the brain. Folia Pharmacol Japon 2009, 133:33P. (in Japanese).
11. Elhwuegi A.S. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:435-451.
12. Eckeli A.L., Dach F., Rodrigues A.L. Acute treatments with GMP produce antidepressant-like effects in mice. Neuroreport 2000, 11:1839-1843.
13. Gavioli E.C., Vaughan C.W., Marzola G., Guerrini R., Mitchell V.A., Zucchini S., et al. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol 2004, 369:547-553.
14. Redrobe J.P., Bourin M., Colombel M.C., Baker G.B. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. J Psychopharmacol 1998, 12:348-355.
15. Zhao Z., Baros A.M., Zhang H.T., Lapiz M.D., Bondi C.O., Morilak D.A., et al. Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology 2008, 33:3190-3200.
16. D'Aquila P.S., Collu M., Pani L., Gessa G.L., Serra G. Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. Eur J Pharmacol 1994, 262:107-111.
17. Yamada J., Sugimoto Y., Yamada S. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol 2004, 504:207-211.
18. Shimazu S., Minami A., Kusumoto H., Yoneda F. Antidepressant-like effects of selegiline in the forced swim test. Eur Neuropsychopharmacol 2005, 15:563-571.
19. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
20. Schreiber R., De Vry J. Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 1993, 4:625-636.
21. Kamei J., Ogawa M., Kasuya Y. Monoamines and the mechanisms of action of antitussive drugs in rats. Arch Int Pharmacodyn Ther 1987, 290:117-127.
22. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
23. Wadenberg M.L., Kapur S., Soliman A., Jones C., Vaccarino F. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology 2000, 150:422-429.
24. Cervo L., Samanin R. Clonidine causes antidepressant-like effects in rats by activating alpha 2-adrenoceptors outside the locus coeruleus. Eur J Pharmacol 1991, 193:309-313.
25. O'Neill M.F., Osborne D.J., Woodhouse S.M., Conway M.W. Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice. J Psychopharmacol 2001, 15:18-22.
26. Malinge M., Bourin M., Colombel M.C., Larousse C. Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test. Psychopharmacology 1988, 96:104-109.
27. Kitada Y., Miyauchi T., Kanazawa Y., Nakamichi H., Satoh S. Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test. Neuropharmacology 1983, 22:1055-1060.
28. Borsini F., Lecci A., Mancinelli A., D'Aranno V., Meli A. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity. Eur J Pharmacol 1988, 148:301-307.
29. Serra G., Collu M., D'Aquila P.S., De Montis G.M., Gessa G.L. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res 1990, 527:234-243.
30. + current in rat dorsal raphe neurons. Jpn J Pharmacol 2000, 82(Suppl. I):112P.
31. Mukai H., Shirasaki T., Soeda F., Takahama K. Electrophysiological analysis on selective blocking action of GIRK channel of cloperastine. Folia Pharmacol Japon 2011, 137:5P. (in Japanese).
32. Kawaura K., Miki R., Shima E., Honda S., Soeda F., Shirasaki T., et al. Antidepressant-like effect of centrally acting non-narcotic antitussive caramiphen in a forced swimming test. Neurosci Lett 2010, 481:188-190.
33. De Vry J., Schreiber R., Melon C., Dalmus M., Jentzsch K.R. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 2004, 14:487-495.
34. Kawaura K., Honda S., Soeda F., Shirasaki T., Takahama K. A novel antidepressant-like action of drugs possessing GIRK channel blocking action in rats. Yakugaku Zasshi 2010, 130:699-705. (in Japanese).